2 publications
-
Published Subscription Original Research
Clone-Specific Drug Delivery Systems: Targeted Approaches and Future Clinical ApplicationsBy Suryakant Kumar, Kamalesh Mistry, Md. Zulphakar Ali, Md. Aftab Alam, Noorul Huda, Neha Nahid
Abstract: Clone-specific drug delivery systems represent a transformative frontier in personalized medicine, addressing the longstanding challenge of clonal heterogeneity within diseases such as cancer, infectious diseases, and autoimmune disorders. Traditional drug delivery platforms often fail to discriminate between pathogenic and healthy cells, leading to systemic toxicity and reduced therapeutic efficacy. In contrast, clone-specific systems aim to selectively target and eliminate disease-driving cellular clones based on unique molecular signatures, thereby improving treatment …
Published in Research & Reviews: A Journal of Drug Design & Discovery · Vol. 12, Issue 2, 2025 · pp. 21–29 Read article →
-
Published Subscription Review Article
Recent Advances in Quality Control and Quality Assurance: Enhancing Pharmaceutical Product Integrity and ComplianceBy Rishabh Viswas, Md Zulphakar Ali, Kamalesh Mistry, Md. Aftab Alam, Noorul Huda, Peeyush Jain
Abstract: The pharmaceutical industry is undergoing a paradigm shift driven by stringent regulatory expectations and the demand for high-quality, safe, and efficacious drug products. Quality Control (QC) and Quality Assurance (QA) serve as the two foundational pillars that ensure pharmaceutical integrity from raw material acquisition through to product release. Traditional QC and QA practices, while effective, have been challenged by complex formulations, biologics, and personalized medicine, requiring innovative methodologies and technologies. …
Published in Research and Reviews: A Journal of Pharmaceutical Science · Vol. 16, Issue 2, 2025 · pp. 54–62 Read article →